OMRON Corporation Fundamental Analysis
OMRON Corporation (OMRNY) shows weak financial fundamentals with a PE ratio of 38.51, profit margin of 3.71%, and ROE of 3.61%. The company generates $777.5B in annual revenue with weak year-over-year growth of -2.08%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 45.6/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze OMRNY's fundamental strength across five key dimensions:
Efficiency Score
WeakOMRNY struggles to generate sufficient returns from assets.
Valuation Score
ModerateOMRNY shows balanced valuation metrics.
Growth Score
WeakOMRNY faces weak or negative growth trends.
Financial Health Score
ExcellentOMRNY maintains a strong and stable balance sheet.
Profitability Score
WeakOMRNY struggles to sustain strong margins.
Key Financial Metrics
Is OMRNY Expensive or Cheap?
P/E Ratio
OMRNY trades at 38.51 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, OMRNY's PEG of 0.00 indicates potential undervaluation.
Price to Book
The market values OMRON Corporation at 1.32 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 12.16 times EBITDA. This signals the market has high growth expectations.
How Well Does OMRNY Make Money?
Net Profit Margin
For every $100 in sales, OMRON Corporation keeps $3.71 as profit after all expenses.
Operating Margin
Core operations generate 7.83 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $3.61 in profit for every $100 of shareholder equity.
ROA
OMRON Corporation generates $1.90 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
OMRON Corporation generates limited operating cash flow of $61.87B, signaling weaker underlying cash strength.
Free Cash Flow
OMRON Corporation generates weak or negative free cash flow of $7.99B, restricting financial flexibility.
FCF Per Share
Each share generates $40.62 in free cash annually.
FCF Yield
OMRNY converts 0.72% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
38.51
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.003
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.32
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.43
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.29
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.83
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.04
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.05
vs 25 benchmark
How OMRNY Stacks Against Its Sector Peers
| Metric | OMRNY Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 38.51 | 37.08 | Neutral |
| ROE | 3.61% | 950.00% | Weak |
| Net Margin | 3.71% | 5908780585.00% | Weak |
| Debt/Equity | 0.29 | 0.43 | Strong (Low Leverage) |
| Current Ratio | 1.83 | 4.96 | Neutral |
| ROA | 1.90% | -295559.00% (disorted) | Weak |
OMRNY outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews OMRON Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
23.15%
Industry Style: Growth, Innovation, High Beta
High GrowthEPS CAGR
-27.73%
Industry Style: Growth, Innovation, High Beta
DecliningFCF CAGR
-35.30%
Industry Style: Growth, Innovation, High Beta
Declining